| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.063 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |